What’s New for Biologics | FDA

What’s New for Biologics | FDA

Complete List of Licensed Products and Establishments

12/9/2019

Complete List of Substantially Equivalent 510(k) Device Applications

12/9/2019

Complete List of Currently Approved Premarket Approvals (PMAs)

12/9/2019

Complete List of Currently Approved NDA and ANDA Application Submissions

12/9/2019

December 6, 2019 Approval Letter - TENIVAC

12/9/2019

BK190333 - Terumo Operational Medical Equipment Software (TOMEs), Version 7.1

12/9/2019

CBER-Regulated Products: Current Shortages

12/9/2019

12/9/2019	Complete List of Licensed Products and Establishments
12/9/2019	Complete List of Substantially Equivalent 510(k) Device Applications
12/9/2019	Complete List of Currently Approved Premarket Approvals (PMAs)
12/9/2019	Complete List of Currently Approved NDA and ANDA Application Submissions
12/9/2019	December 6, 2019 Approval Letter - TENIVAC
12/9/2019	BK190333 - Terumo Operational Medical Equipment Software (TOMEs), Version 7.1
12/9/2019	CBER-Regulated Products: Current Shortages
12/6/2019	Public Safety Notification on Exosome Products
12/5/2019	December 3, 2019 Approval Letter - Panoscreen EXTEND
12/5/2019	User Fee Billable Biologic Products and Potencies Approved Under Section 351 of PHS Act
12/5/2019	Influenza Vaccine for the 2019-2020 Season
12/5/2019	Job Vacancy Announcement: Physician, Division of Epidemiology (DE) - Title 38(F) Physician (GP-0602)
12/4/2019	December 3, 2019 Approval Letter - Data-Cyte Plus 2, and Data-Cyte Extend  0.8 % Reagent Red Blood Cells
12/4/2019	BK190389 - ALBAcheck BGS Monoclonal Control
12/3/2019	November 25, 2019 Untitled Letter - Chara Biologics, Inc.
12/3/2019	Exceptions and Alternative Procedures Approved Under 21 CFR 640.120
12/2/2019	March 3, 2020 Workshop - Facilitating End-to-End Development of Individualized Therapeutics
11/29/2019	November 26, 2019 Approval Letter - Pneumovax 23
11/27/2019	November 25, 2019 Order to Cease Manufacturing - Gynecology, Reproductive Endocrinology and Fertility Institute (GREFI)
11/27/2019	Influenza Vaccine for the 2019-2020 Season
11/25/2019	FDA Zika virus reference panel for molecular-based diagnostic devices supports product testing for Emergency Use Authorization and 510(k) submissions
11/22/2019	November 20, 2019 Untitled Letter - RichSource Stem Cells, Inc.
11/21/2019	Influenza Vaccine for the 2019-2020 Season
11/18/2019	2019 Biological Device Application Approvals
11/18/2019	2019 Biological New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) Approvals
11/18/2019	November 7, 2019 - Anti-Fyb (Murine Monoclonal) (Recombinant)
11/18/2019	November 7, 2019 - Anti-Fya (Murine Monoclonal) (Recombinant)
11/15/2019	SOPP 8116: Use of Electronic Signatures for Regulatory Documents
11/14/2019	Influenza Vaccine for the 2019-2020 Season
11/13/2019	November 12, 2019 Approval Letter - Rotarix
11/13/2019	CBER-Regulated Products: Current Shortages
11/12/2019	BK190349 - RD2 System